Actively Recruiting
Goal Management Training for Cognitive Control Improvement After Acquired Brain Injury
Led by St. Olavs Hospital · Updated on 2025-12-02
116
Participants Needed
1
Research Sites
2 weeks
Total Duration
On this page
Sponsors
S
St. Olavs Hospital
Lead Sponsor
N
Norwegian University of Science and Technology
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying how Goal Management Training (GMT) can improve cognitive control in people who have had an acquired brain injury (ABI). The study aims to identify factors that predict how well patients respond to GMT and to assess the effects of additional support through a smartphone app and a booster module. The trial includes adults aged 18 to 65 years who have cognitive control difficulties at least 12 months after their brain injury or surgery. Participants receive Goal Management Training in small groups of 4 to 6 patients at a rehabilitation hospital. The standard GMT program involves 10 sessions delivered twice a day, once a week, over five weeks. Half of the participants will get extra daily reminders via a smartphone app during the training period to help with homework tasks. After the main training, half of the participants will be randomly chosen to receive a booster module three months later to support longer-lasting benefits. During the study, participants complete cognitive tests and self-report questionnaires before treatment, right after, at six months, and one year later. The primary outcome measured is the Global Executive Composite score from the BRIEF-A questionnaire. Researchers will also use other cognitive tests and questionnaires to evaluate progress. The study includes regular assessments and uses advanced statistical methods to analyze how different treatments and patient characteristics affect outcomes over time.
CONDITIONS
Brief Title
Goal Management Training (GMT) for Improvement of Cognitive Control Function After Acquired Brain Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18-65 years
- Acquired brain injury at least 12 months prior to enrollment
- Reporting cognitive control problems by structured interview or clinical performance measures
- No concomitant diseases
You will not qualify if you...
- Non-fluency in Norwegian language
- Major psychiatric disorder or ongoing alcohol or substance abuse
- Premorbid neurological disease, insult, or comorbid neurological disease
- Aphasia or other language problems causing communication issues
- Impaired basic linguistic, memory, motor, or perceptual function interfering with training
- Estimated IQ below 85
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 5 weeks
Participants receive Goal Management Training (GMT) in groups of 4-6 patients. The standard treatment consists of 10 sessions, delivered as 2 sessions a day, one day per week, over 5 weeks. Some participants receive additional daily reminder messages via a smartphone app during part of the treatment to support homework completion.
10 treatment sessions delivered over 5 weeks
Duration - 1 day
Participants complete assessments immediately after treatment, including various cognitive and behavioral measures to evaluate treatment effects.
1 visit (in-person) immediately after treatment
Duration - 1 session (single day)
Some participants receive an additional booster module 3 months after the last GMT session to support prolonged treatment response.
1 booster session approximately 3 months after treatment completion
Duration - Up to 1 year
Participants are monitored with follow-up assessments at 6 months and 1 year after treatment to evaluate long-term effects.
2 follow-up visits at 6 months and 1 year after treatment
Trial Site Locations
Total: 1 location
1
St. Olavs Hospital
Trondheim, Norway, 7030
Actively Recruiting
Research Team
A
Alexander Olsen, PhD
J
Janne-Birgitte Børke
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here